Treatment with a soluble activin receptor type IIB attenuates glucocorticoid-induced muscle loss

被引：0
作者：
Lachey, J. [1 ]
Pullen, A. [1 ]
Pearsall, R. [1 ]
Seehra, J. [1 ]
机构：
[1] Acceleron Pharma, Cambridge, MA USA
来源：
NEUROMUSCULAR DISORDERS | 2007年 / 17卷 / 9-10期
关键词：
D O I：
10.1016/j.nmd.2007.06.087
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：785 / 785
页数：1
相关论文
共 50 条
  • [21] Soluble glucocorticoid-induced TNF receptor (sGITR) induces inflammation in mice
    Shin, HH
    Kim, SG
    Lee, MH
    Suh, JH
    Kwon, BS
    Choi, HS
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2003, 35 (05) : 358 - 364
  • [22] Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor
    Rahimov, Fedik
    King, Oliver D.
    Warsing, Leigh C.
    Powell, Rachel E.
    Emerson, Charles P., Jr.
    Kunkel, Louis M.
    Wagner, Kathryn R.
    PHYSIOLOGICAL GENOMICS, 2011, 43 (08) : 398 - 407
  • [23] Skeletal Response to Soluble Activin Receptor Type IIB in Mouse Models of Osteogenesis Imperfecta
    Jeong, Youngjae
    Daghlas, Salah A.
    Xie, Yixia
    Hulbert, Molly A.
    Pfeiffer, Ferris M.
    Dallas, Mark R.
    Omosule, Catherine L.
    Pearsall, R. Scott
    Dallas, Sarah L.
    Phillips, Charlotte L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (10) : 1760 - 1772
  • [24] SOLUBLE ACTIVIN RECEPTOR TYPE IIB INCREASES FORWARD PULLING TENSION IN THE mdx MOUSE
    Carlson, C. George
    Bruemmer, Kay
    Sesti, Jenna
    Stefanski, Casey
    Curtis, Heather
    Ucran, Jeffrey
    Lachey, Jennifer
    Seehra, Jasbir S.
    MUSCLE & NERVE, 2011, 43 (05) : 694 - 699
  • [25] The use of a soluble activin receptor type IIa as a novel anabolic agent for treatment of bone loss
    Pearsall, R. S.
    Cornwall-Brady, M.
    Mangini, M.
    Barbosa, D.
    Seehra, J.
    Stadmeyer, L.
    Glatt, V.
    Rosen, E.
    Canalis, E.
    Bouxsein, M. L.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S152 - S152
  • [26] The use of a soluble activin receptor type IIA as a novel anabolic agent for treatment of bone loss
    Pearsall, Scott
    Cornwall-Brady, Milton
    Mangini, Michelle
    Barbosa, Denise
    Stadmeyer, Lisa
    Rosen, Eyal
    Canalis, Ernesto
    Bouxsein, Mary L.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S193 - S194
  • [27] The Role of LXR in Glucocorticoid-Induced Muscle Wasting and Bone Loss.
    Williams-Dautovich, Jasmine
    Patel, Rucha
    Cummins, Carolyn L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S266 - S266
  • [28] Treatment with a soluble activin type II receptor reverses bone loss in ovariectomized mice.
    Pearsall, R. S.
    Cornwall-Brady, M.
    Lachey, J.
    Glatt, V.
    Bouxsein, M. L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S26 - S26
  • [29] Glucocorticoid-induced bone loss in children
    Gordon L. Klein
    Clinical Reviews in Bone and Mineral Metabolism, 2004, 2 (1): : 37 - 52
  • [30] Glucocorticoid-induced skeletal muscle atrophy
    Schakman, O.
    Kalista, S.
    Barbe, C.
    Loumaye, A.
    Thissen, J. P.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2013, 45 (10) : 2163 - 2172
12345